1887

Chapter 21 : Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap21-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap21-2.gif

Abstract:

Recent studies have indicated that umbilical cord blood (CB) represents a rich source of CD34 hematopoietic stem/progenitor cells, and consequently, there has been a proliferation of CB banks worldwide. Currently, the enumeration of CD34 stem/progenitor cells by flow cytometry represents the most clinically useful surrogate marker of graft adequacy and provides crucial information to the transplant physician. While flow cytometric enumeration of CD34 cells represents the most clinically useful assay of graft assessment, the assays that were initially developed were insufficiently robust, and interinstitutional variability in particular was problematic. An increasing array of ex vivo manipulations has been developed to engineer the graft to suit specific clinical requirements. Included in the latter are positive selection techniques to purify CD34 cells and negative purging techniques to remove residual tumor cells in the autologous setting, or T lymphocytes in the allogeneic setting. Finally, there is widespread interest in the development of clinically useful ex vivo expansion methodologies and gene therapy protocols. At present, the authors feel that the methodologies based on the original International Society of Hematotherapy and Graft Engineering (ISHAGE) protocol and updated in Current Protocols in Cytometry (CPC) represent the most accurate and flexible protocols currently available to both clinical and research laboratories for the analysis of the increasingly wide variety of normal and abnormal hematopoietic samples.

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21

Key Concept Ranking

Multiparameter Flow Cytometry
0.46179307
Flow Cytometric Assay
0.43703848
White Blood Cells
0.40721607
0.46179307
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Enumeration of CD34 cells in a CB sample stained with CD34-PE and CD45-FITC (clones 581 and J33, respectively; Immunotech-Coulter) using the basic ISHAGE protocol ( ). Plot A is gated on all events, plot B is gated on R1 events, plot C is gated on R1 and R2 events, and plot D is gated on R1, R2, and R3 events. Plot E is gated on all events, and plot F is gated lymphocytes back-scattered from R5 (plot A) to ensure optimal placement of lymphblast region R4 as described previously ( ). Plots G and H show the same sample stained with isotype control IgG1-PE and CD45-FITC. Only two plots (equivalent to plots C and D) are shown for the control sample. No events satisfying the gating criteria of plots A to D are found in R4 of plot H. Gate statistics are obtained from plot B (CD45 events).

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Absolute viable CD34-cell counting using the single-platform ISHAGE protocol ( ) performed on 100 μl of a 24-h-old PBSC sample stained with CD34-FITC and CD45-PE. After 25 min, the sample was lysed with 2 ml of NHCl containing 1 μg of 7-AAD. After 10 min at room temperature, 100 μl of Flow-Count beads was added and the sample was analyzed immediately as described previously ( ). Dead cells (7-AAD) gated in R8 and were removed from analysis by logical gating as depicted in plots B, C, D, and F. A total of 456 viable CD34 cells were counted in gate 4 (not R8 and R1 through R4), 4,082 beads were counted in gate 7 (R6 and R7), and the assayed bead concentration was 1,046/μl. The sample contains 117 viable CD34 cells/μl.

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Importance of removing dead cells in accurate enumeration of CD34 cells by the single-platform ISHAGE protocol. The list mode file from the same 24-h-old sample as shown in Fig. 2 was analyzed without prior removal of nonviable (7-AAD) cells. Note that most nonviable CD34 cells and nonviable lymphocytes (plots D and F, respectively) form a second cluster characterized by lower FSC compared to their viable equivalents shown on the corresponding plots of Fig. 2 . The sample contains 162 total CD34 cells/μl.

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Absolute viable CD34-cell counting with the ISHAGE single-platform protocol using TruCOUNT tubes. Fifty microliters of a fresh peripheral blood sample was stained with CD45-FITC and CD34-PE in a TruCOUNT tube. A threshold was established on FL1 (CD45-FITC) because the size of the TruCOUNT beads precludes the use of an FSC threshold. The total number of beads in the list mode file is obtained from gate 7 (R6 and R7). Gate statistics are obtained from plot A (all events). The sample contains 205 viable CD34 cells/μl.

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

Identifying CD34-cell subsets using the CPC support protocol ( ) and PBSC sample stained with CD34-FITC and CD45-PE-Cy5. CD34 cells (1.01% of the gated CD45 events) were identified as described for Fig. 1 , plots A to D (plots A and B not shown), and displayed on CD34 versus FL2 to establish positive cell analysis R5 (plot E). Plot F displays gated lymphocytes (from plot B) on a CD45-versus-FL2 plot. Note that the back-scattered lymphocytes have autofluorescence similar to that of gated CD34 cells (plot E) and cluster parallel with the horizontal axis, indicating optimized FL2/FL3 fluorescence compensation. Plots G and H show the staining of CD34 cells and lymphocytes, respectively, with CD90/Thy-1-PE. Plots J and K show the staining of the CD34 cells with CD133-PE and CD33-PE, respectively.

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

Identifying CD34-cell subsets in the marrow of a poor mobilizer. CD34 cells (2.00% of the total CD45 events in G4) are identified in plots A to D (A and B not shown). The majority of CD34 cells exhibit light scatter characteristics of prelymphoid cells. An unstained control (no PE conjugate) of the gated CD34 cells from R4 was used to establish gating R5 (plot E). Plots F, G, H, and J show the staining of gated CD34 cells with CD90/Thy-1, AC133, CD38, and CD33, respectively. The lower right plot shows the light scatter of the CD34 CD33 cells.

Citation: Sutherland D, Chin-Yee I, Keeney M, Gratama J. 2006. Standardized Flow Cytometry Assays for Enumerating Hematopoietic Stem Cells, p 187-200. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815905.ch21
1. Barnett, D.,, V. Granger,, J. Kraan,, L. Whitby,, J. T. Reilly,, S. Papa, and , J. W. Gratama. 2000. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. CD34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br. J. Haematol. 108:784792.
2. Barnett, D.,, G. Janossy,, A. Lubenko,, E. Matutes,, A. Newland, and , J. T. Reilly. 1999. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin. Lab. Haematol. 21:301308.
3. Bender, J. G.,, K. Unverzagt, and , D. Walker. 1994. Guidelines for determination of CD34+ cells by flow cytometry: application to the harvesting and transplantation of peripheral blood stem cells, p. 3143. In E. Wunder,, H. Sovalat,, P. R. Henon, and , S. Serke (ed.), Hematopoietic Stem Cells: the Mulhouse Manual. AlphaMed Press, Dayton, Ohio.
4. Berenson, R. J.,, R. G. Andrews,, W. I. Bensinger,, D. Kalamasz,, G. Knitter,, C. D. Buckner, and , I. D. Bernstein. 1988. Antigen CD34-positive marrow cells engraft lethally irradiated baboons. J. Clin. Investig. 81:951955.
5. Borowitz, M. J.,, K. L. Guenther,, K. E. Schultz, and , G. T. Stelzer. 1993. Immuno-phenotyping of acute leukemia by flow cytometry: use of CD45 and right angle light scatter to gate on leukemic blasts in three color analysis. Am. J. Clin. Pathol. 100:534540.
6. Brecher, M. E.,, L. Sims,, J. Schmitz,, T. Shea, and , S. A. Bentley. 1996. North American multicenter study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J. Hematother. 5:227236.
7. Brocklebank, A. M., and , R. L. Sparrow. 2001. Enumeration of CD34+ cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry 46:254261.
8. Cairo, M. S., and , J. E. Wagner. 1997. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 90:46654678.
9. Chang, A., and , D. D. F. Ma. 1996. The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. J. Hematother. 5:605616.
10. Chin-Yee, I.,, M. Keeney,, L. Anderson,, R. Nayar, and , D. R. Sutherland. 1997. Current status of CD34+ cell analysis by flow cytometry: the ISHAGE Guidelines. Clin. Immunol. Newsl. 17:2129.
11. Civin, C.,, T. Trischman,, M. J. Fackler,, I. Bernstein,, H. Buhring,, L. Campos,, M. F. Greaves,, M. Kamoun,, D. Katz,, P. Lansdorp,, T. Look,, B. Seed,, D. R. Sutherland,, R. Tindle, and , B. Uchanska-Zeigler. 1989. Summary of CD34 cluster workshop section, p. 818825. In W. Knapp,, B. Dorken,, W. R. Gilks,, E. P. Rieber,, R. E. Schmidt,, H. Stein, and , A. E. G. K. von dem Borne (ed.), Leucocyte Typing IV. Oxford University Press, Oxford, United Kingdom.
12. Gazitt, Y.,, E. Tian,, B. Barlogie,, C. L. Reading,, D. H. Vesole,, S. Jagannath,, J. Schnell,, R. Hoffman, and , G. Tricot. 1996. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma following treatment with cyclophosphamide and GM-CSF. Blood 87:805811.
13. Gratama, J.,, A. Orfao,, D. Barnett,, B. Brando,, A. Huber,, G. Janossy,, H. E. Johnsen,, M. Keeney,, G. E. Marti,, F. Preijers,, G. Rothe,, S. Serke,, D. R. Sutherland,, C. E. Van Der Schoot,, G. Schmitz, and S. Papa for the European Working Group on Clinical Cell Analysis. 1998. Flow cytometric enumeration of CD34+ hematopoietic progenitor cells. Cytometry 34:128142.
14. Gratama, J. W.,, M. Keeney, and , D. R. Sutherland. 1999. Enumeration of CD34+ hematopoietic stem and progenitor cells, p 6.4.16.4.22. In J. P. Robinson,, Z. Darzynkiewicz,, P. N. Dean,, A. R. Hibbs,, A. Orfao,, P. S. Rabinovitch, and , L. L. Wheeless (ed.), Current Protocols in Cytometry. John Wiley and Sons Inc., New York, N.Y.
15. Gratama, J. W.,, J. Kraan,, M. Keeney,, D. R. Sutherland,, V. Granger, and , D. Barnett. 2003. Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 5:5565.
16. Gratama, J. W.,, J. Kraan,, W. Levering,, D. R. Van Bockstaele,, G. T. Rijkers, and , C. E. Van der Schoot. 1997. Analysis of variation in results of CD34+ hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 30:109117.
17. Gutensohn, K.,, I. Carrero,, W. Krueger,, N. Kroeger,, P. Schafer,, K. Luedemann, and , P. Kuehnl. 1999. Semiautomated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products. Transfusion 39:12201226.
18. Johnsen, H. E.,, J. Baech, and , K. Nicolajsen. 1999. Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: report from the third workshop. J. Hematother. 8:1528.
19. Keeney, M.,, I. Chin-Yee,, J. W. Gratama, and , D. R. Sutherland. 1998. Perspectives: isotype controls in the analysis of lymphocytes and CD34+ stem/progenitor cells by flow cytometry—time to let go! Cytometry 34:280283.
20. Keeney, M.,, I. Chin-Yee,, K. Weir,, J. Popma,, R. Nayar, and , D. R. Sutherland. 1998. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE Guidelines. Cytometry 34:6167.
21. Lanza, R.,, L. Healy, and , D. R. Sutherland. 2001. Structural and functional features of the CD34 antigen: an update. J. Biol. Regulators Homeostatic Agents 15:113.
22. Luider, J.,, C. Brown,, S. Selinger,, D. Quinlan,, L. Karlsson,, D. Ruether,, D. Stewart,, J. Klassen, and , J. A. Russell. 1997. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis. J. Hematother. 6:575580.
23. Mancuso, P.,, A. Burlini,, G. Pruneri,, A. Goldhirsch,, G. Martinelli, and , F. Bertolini. 2001. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97:36583661.
24. Murray, L.,, B. Chen,, A. Galy,, S. Chen,, R. Tushinski,, N. Uchida,, R. Negrin,, G. Tricot,, S. Jagannath,, D. Vesole,, B. Barlogi,, R. Hoffman, and , A. Tsukamoto. 1985. Enrichment of human hematopoietic stem cell activity in the CD34+Thy1+Lin- subpopulation from mobilized peripheral blood. Blood 85:368378.
25. Negrin, R. S.,, K. Atkinson,, T. Leemhuis,, E. Hanania,, C. Juttner,, D. Tierney,, W. W. Hu,, L. J. Johnston,, J. A. Shizuru,, K. E. Stockerl-Goldstein,, K. G. Blume,, I. L. Weissman,, S. Bower,, R. Baynes,, R. Dansey,, C. Karanes,, W. Peters, and , J. Klein. 2000. Transplantation of highly purified CD34+ Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol. Blood Marrow Transplant. 6:262271.
26. Owens, M. A., and , M. R. Loken. 1995. Peripheral blood stem cell quantitation, p. 111127. In M. A. Owens and , M. R. Loken (ed.), Flow Cytometric Principles for Clinical Laboratory Practice. Wiley-Liss, New York, N.Y.
27. Siena, S.,, M. Bregni,, B. Brando,, N. Belli,, F. Ravagnani,, L. Gandola,, A. C. Stern,, P. M. Lansdorp,, G. Bonadonna, and , A. M. Gianni. 1991. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400409.
28. Siena, S.,, M. Bregni,, B. Brando,, F. Ravagnani,, G. Bonadonna, and , A. M. Gianni. 1989. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocytemacrophage colony-stimulating factor. Blood 74:19051914.
29. Stewart, A. K.,, K. Imrie,, A. Keating,, S. Anania,, R. Nayar, and , D. R. Sutherland. 1995. Optimizing the CD34+ Thy-1+ stem cell content of peripheral blood collections. Exp. Hematol. 23:16191627.
30. Sutherland, D. R., and , A. Keating. 1992. The CD34 antigen: structure, biology and potential clinical applications. J. Hematother. 1:115129.
31. Sutherland, D. R.,, L. Anderson,, M. Keeney,, R. Nayar, and , I. Chin-Yee. 1996. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J. Hematother. 5:213226.
32. Sutherland, D. R.,, A. Keating,, R. Nayar,, S. Anania, and , A. K. Stewart. 1994. Sensitive detection and enumeration of CD34+ cells in peripheral blood and cord blood by flow cytometry. Exp. Hematol. 22:10031010.
33. Sutherland, D. R.,, M. Keeney, and , J. W. Gratama. 2003. Enumeration of CD34+ hematopoietic stem and progenitor cells, p. 6.4.16.4.23. In J. P. Robinson,, Z. Darzynkiewicz,, P. H. Dean,, L. G. Dressler,, P. S. Rabinovitch,, C. S. Stewart,, H. J. Tanke, and , L. L. Wheeless (ed.), Current Protocols in Cytometry. John Wiley and Sons Inc., New York, N.Y.
34. Sutherland, D. R.,, E. L. Yeo,, A. K. Stewart,, R. Nayar,, R. DiGiusto,, R. Hoffman,, E. D. Zanjani, and , L. J. Murray. 1996. Identification of CD34+ subsets following glycoprotease selection: engraftment of CD34+/Thy-1+/Lin- stem cells in fetal sheep. Exp. Hematol. 24:795806.
35. To, L. B.,, D. N. Haylock,, P. J. Simmons, and , C. A. Juttner. 1997. The biology and clinical uses of blood stem cells. Blood 89:22332258.
36. Watts, M. J.,, A. M. Sullivan,, D. Leverett,, A. J. Peniket,, A. R. Perry,, C. D. Williams,, S. Devereux,, A. H. Goldstone, and , D. C. Linch. 1995. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization. J. Clin. Oncol. 16:15541560.
37. Weaver, C. H.,, B. Hazelton,, R. Birch,, P. Palmer,, C. Allen,, L. Schwartzberg, and , W. West. 1995. An analysis of engraftment kinetics as a function of CD34 cell content of peripheral blood progenitor collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:39613969.
38. Yin, A. H.,, S. Miraglia,, E. D. Zanjani,, G. Almeida-Porada,, M. Ogawa,, A. G. Leary,, J. Olweus,, J. Kearney, and , D. W. Buck. 1997. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:50025012.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error